Bridgeway Capital Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-50,000
| Closed | -$88K | – | 1330 |
|
|
2024
Q3 | $88K | Buy |
+50,000
| New | +$88K | ﹤0.01% | 1169 |
|
|
2020
Q2 | – | Sell |
-69,650
| Closed | -$566K | – | 1415 |
|
|
2020
Q1 | $566K | Sell |
69,650
-23,950
| -26% | -$195K | 0.01% | 727 |
|
|
2019
Q4 | $809K | Buy |
93,600
+50,000
| +115% | +$432K | 0.01% | 797 |
|
|
2019
Q3 | $269K | Sell |
43,600
-2,800
| -6% | -$17.3K | ﹤0.01% | 1117 |
|
|
2019
Q2 | $770K | Buy |
46,400
+12,500
| +37% | +$207K | 0.01% | 824 |
|
|
2019
Q1 | $567K | Buy |
33,900
+15,973
| +89% | +$267K | 0.01% | 994 |
|
|
2018
Q4 | $206K | Sell |
17,927
-10,000
| -36% | -$115K | ﹤0.01% | 1214 |
|
|
2018
Q3 | $1.12M | Buy |
27,927
+13,525
| +94% | +$541K | 0.01% | 840 |
|
|
2018
Q2 | $407K | Buy |
+14,402
| New | +$407K | ﹤0.01% | 1193 |
|
|
2017
Q2 | – | Sell |
-7,500
| Closed | -$53K | – | 1483 |
|
|
2017
Q1 | $53K | Hold |
7,500
| – | – | ﹤0.01% | 1361 |
|
|
2016
Q4 | $30K | Hold |
7,500
| – | – | ﹤0.01% | 1391 |
|
|
2016
Q3 | $55K | Sell |
7,500
-11,375
| -60% | -$83.4K | ﹤0.01% | 1400 |
|
|
2016
Q2 | $96K | Buy |
18,875
+6,250
| +50% | +$31.8K | ﹤0.01% | 1384 |
|
|
2016
Q1 | $272K | Hold |
12,625
| – | – | ﹤0.01% | 1235 |
|
|
2015
Q4 | $386K | Buy |
12,625
+2,000
| +19% | +$61.1K | 0.01% | 1141 |
|
|
2015
Q3 | $354K | Buy |
10,625
+3,125
| +42% | +$104K | 0.01% | 1169 |
|
|
2015
Q2 | $348K | Buy |
+7,500
| New | +$348K | 0.01% | 1206 |
|